Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- LUCIGEN CORPORATION
- Proposal award date
- 2016-07-01
- Contract end date
- 2018-06-30
- UEI
- L9SNJEY728V3
- Solicitation number
- PA15-269
- Topic code
- NIAID
Research abstract
Expensive equipment highly trained personnel and the need for a clinical laboratory setting precludes
routine nucleic acid testing NAT for infectious disease in most of the developing world and even in many
resource limited parts of the United States leading to wide disparities in health care worldwide A fast
sensitive low cost but a facile NAT method for robust detection of specific agents at the point of care POC
would help bring molecular diagnostics to everyone
The goal of this application is to demonstrate feasibility of a complete field appropriate molecular detection
system suitable for use in low resource settings for the detection of three important arboviruses Chikungunya
CHIKV Zika ZIKV and dengue DENV The innovative technology that is the basis of this application is a
new thermostable polymerase OmniAmp which has innate reverse transcriptase RT activity OmniAmp is
suitable for application in a promising NAT alternative to the polymerase chain reaction PCR called loop
mediated isothermal amplification LAMP Since LAMP is isothermal it does not require specialized
instrumentation plus it is much faster than PCR LAMP is also resistant to inhibitors in crude sample
preparations The proposed assay will be based on LAMP using OmniAmp polymerase and performed on a
simple easy to use automated molecular detection MDx platform Total assay time will be minutes with
minimal hands on time and without need of any additional equipment such as pipettes centrifuge etc Results
will be displayed on screen as positive or negative for a specific pathogen minimizing error s caused by user
interpretation
LAMP assays for detection of all major lineages of CHIKV and ZIKV including strains now circulating in
the Americas and all serotypes of DENV will be developed Performance of LAMP assays will be compared
to that of reference real time RT PCR methods For field use a simple and rapid sample preparation method for
extraction of nucleic acid from samples whole blood and serum will also be developed In order to increase
the shelf life of reagents amplification reagents will be dried down Analytical sensitivity and specificity will be
evaluated by testing whole blood and serum samples by spiking them with different titers of CHIKV ZIKV and
DENV serotype both individually and co infection
By combining Lucigen s capacity in amplification and detection with the expertise in arboviral research and
fundamental capability provided by the University of Texas Medical Branch a molecular detection system will
be developed for detection and differentiation of CHKV ZIKV and DENV that can be implemented almost
anywhere worldwide
Successful completion of this project will lead to
Development of molecular diagnostic assay for detection and differentiation of three important arboviruses
CHIKV ZIKV and DENV at POC
Total assay time of minutes including sample preparation and run time
Detection of multiple targets in a single run from single sample prep
Dried reagents for storage at ambient temperature
A technology platform that can be adapted for the detection of other pathogens A simple and easy to use molecular test for detection and differentiation of arboviruses at the
point of care would bring the power of molecular diagnostics to low resource settings The goal
of this application is to demonstrate feasibility of a complete field appropriate molecular
diagnostic system for the detection of three important arboviruses Chikungunya Zika and
Dengue that can be used anywhere in the world with minimal infrastructural support and
training The results of this assay will be available in minutes allowing healthcare providers
to initiate appropriate actions
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
Research funding history
51 SBIR/STTR records share this UEI (2000–2016). Reported award amounts total $23,195,889. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, National Science Foundation, Department of Agriculture, Department of Energy
Agency intelligence
Department of Health and Human Services
Back to SBIR/STTR Research Awards